MAPT and esophageal squamous cell carcinoma: Prognosis-related immune-gene-based model based on BMP1, EGFR, S100A12, HLA-B, TNFSF18, IL1B, and MAPT had proved to be useful for prognosis in ESCC (Fei et al., 2021).